Bangerter M - Search Results

1

Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease.

Bangerter M, Moog F, Buchmann I, Kotzerke J, Griesshammer M, Hafner M, Elsner K, Frickhofen N, Reske SN, Bergmann L. Bangerter M, et al. Ann Oncol. 1998 Oct;9(10):1117-22. doi: 10.1023/a:1008486928190. Ann Oncol. 1998. PMID: 9834825 Free article.

2

New diagnostic imaging procedures in Hodgkin's disease.

Bangerter M, Griesshammer M, Binder T, Hafner M, Heimpel H, Reske SN, Frickhofen N. Bangerter M, et al. Ann Oncol. 1996;7 Suppl 4:55-9. doi: 10.1093/annonc/7.suppl_4.s55. Ann Oncol. 1996. PMID: 8836411 Review.

3

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.

Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E, Kolokythas O, Herrmann F, Reske SN. Moog F, et al. Among authors: bangerter m. Radiology. 1997 Jun;203(3):795-800. doi: 10.1148/radiology.203.3.9169707. Radiology. 1997. PMID: 9169707

4

Extranodal malignant lymphoma: detection with FDG PET versus CT.

Moog F, Bangerter M, Diederichs CG, Guhlmann A, Merkle E, Frickhofen N, Reske SN. Moog F, et al. Among authors: bangerter m. Radiology. 1998 Feb;206(2):475-81. doi: 10.1148/radiology.206.2.9457202. Radiology. 1998. PMID: 9457202

5

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.

Moog F, Bangerter M, Kotzerke J, Guhlmann A, Frickhofen N, Reske SN. Moog F, et al. Among authors: bangerter m. J Clin Oncol. 1998 Feb;16(2):603-9. doi: 10.1200/JCO.1998.16.2.603. J Clin Oncol. 1998. PMID: 9469348

6

Usefulness of FDG-PET in diagnosing primary lymphoma of the liver.

Bangerter M, Moog F, Griesshammer M, Merkle E, Hafner M, Ellenrieder V, Reske SN, Heimpel H. Bangerter M, et al. Int J Hematol. 1997 Dec;66(4):517-20. doi: 10.1016/s0925-5710(97)00068-6. Int J Hematol. 1997. PMID: 9479878

7

Progress in medical imaging of lymphoma and Hodgkin's disease.

Bangerter M, Griesshammer M, Bergmann L. Bangerter M, et al. Curr Opin Oncol. 1999 Sep;11(5):339-42. doi: 10.1097/00001622-199909000-00004. Curr Opin Oncol. 1999. PMID: 10505769 Review.

8

Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest.

Bangerter M, Kotzerke J, Griesshammer M, Elsner K, Reske SN, Bergmann L. Bangerter M, et al. Acta Oncol. 1999;38(6):799-804. doi: 10.1080/028418699432969. Acta Oncol. 1999. PMID: 10522771

9

3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.

Wagner M, Seitz U, Buck A, Neumaier B, Schultheiss S, Bangerter M, Bommer M, Leithäuser F, Wawra E, Munzert G, Reske SN. Wagner M, et al. Among authors: bangerter m. Cancer Res. 2003 May 15;63(10):2681-7. Cancer Res. 2003. PMID: 12750297

10

The abundant presence of Söderström bodies in cytology smears of fine-needle aspirates contributes to distinguishing high-grade non-Hodgkin's lymphoma from carcinoma and sarcoma.

Bangerter M, Herrmann F, Griesshammer M, Gruss HJ, Hafner M, Heimpel H, Binder T. Bangerter M, et al. Ann Hematol. 1997 Apr;74(4):175-8. doi: 10.1007/s002770050278. Ann Hematol. 1997. PMID: 9174545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters